The new BHF Oxford Centre of Research Excellence (BHF Oxford CRE) has launched today at the University of Oxford. Building on three previous Centre awards since 2008, the BHF Oxford CRE unites the University’s cross-disciplinary cardiovascular research community. From discovery science through to clinical and population health research, the BHF Oxford CRE will continue to advance cardiovascular sciences and benefit for patients.
Professor Keith Channon, Director of the BHF Oxford CRE said “We are delighted to receive this renewed support from the BHF to continue the excellent research that is being done by our strong and diverse network of researchers in Oxford. With teams spanning across multiple disciplines we can address new targeted and critical areas of research for the cardiovascular sciences – with the overall goal of translating discoveries from the laboratory through to clinical practice. Through our early- to mid-career development and training opportunities we are continuing to promote a diverse and inclusive research culture allowing our researchers to compete at the highest level and nurture them to become future cardiovascular research leaders.”
With the new round of funding, the BHF Oxford CRE has three key research themes in areas where it sees clear potential to deliver world leading advances:
Led by Professor Cornelia van Duijn and co-led by Professor Blanca Rodriguez, the Big Data & Computational Science theme builds on the Centre’s capabilities in data analysis for population cardiovascular health, including a new focus on vascular dementia. We are working in collaboration between cardiologists, engineers and computer scientists to extend upon big data techniques, artificial intelligence, modelling and simulation which will provide new insights into treatments for cardiovascular disease.
Read the full story on the Radcliffe Department of Medicine website.
more recommended stories
New therapies developed by Oxford experts offer online support for anxiety and post-traumatic stress disordersUrgent treatment solutions are needed for.
three key pillars to tackle antimicrobial resistance effectively — University of Oxford, Medical Sciences DivisionThe High-Level Meeting on antimicrobial resistance.
Oxford Vaccine Group marks 30 years battling ‘deadly six’ diseases with major art installation — University of Oxford, Medical Sciences DivisionThe installation was commissioned to mark.
Professor Ahmed Awarded Funding To Create World’s First Ovarian Cancer Prevention Vaccine — University of Oxford, Medical Sciences DivisionScientists at the University of Oxford,.
New research network unites Oxford University’s global fight against antimicrobial resistance — University of Oxford, Medical Sciences DivisionAntimicrobial resistance (AMR) threatens the foundation.
Typhoid vaccine trial confirms sustained protection for older children — University of Oxford, Medical Sciences DivisionThe TyVOID study, published in the Lancet, measured the.
Study Publishes New Insights on Goblet Cell Differentiation in Colorectal Cancer — University of Oxford, Medical Sciences DivisionThe research addresses the long-recognized poor.
Four Oxford researchers win prestigious Philip Leverhulme Prizes — University of Oxford, Medical Sciences DivisionOnly 30 prizes are awarded throughout.
Kavli Oxford’s Nick Gatford Wins Image of Distinction Award in Nikon Small World Competition — University of Oxford, Medical Sciences DivisionThe Nikon Small World competition, often.
Ineos Oxford Institute awards over £2m to innovative projects to tackle antimicrobial resistance — University of Oxford, Medical Sciences DivisionThe IOI Synergy Grants scheme is.
Leave a Comment